Etiology and pathomorphology of the endometriosis;Etiologia i patomorfologia endometriozy

Medycyna Weterynaryjna

Volumn 60, Issue 3, 2004, Pages 232-236

  Madej, Janusz A ^a,b  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b NONE   (Poland)

Author keywords

Adenomyosis; Endometriosis; Etiology; Pathogenesis

Indexed keywords

AROMATASE; CARBONATE DEHYDRATASE; CATHEPSIN; EPIDERMAL GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR 1; INTEGRIN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 8; PLATELET DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR ALPHA;

ADENOMYOSIS; CLINICAL RESEARCH; ENDOMETRIOSIS; ENDOMETRIUM; ENDOMETRIUM HYPERPLASIA; INFERTILITY; MALIGNANT TRANSFORMATION; PATHOPHYSIOLOGY; PROTO ONCOGENE; REVIEW; SPONTANEOUS ABORTION;

EID: 1642322041     PISSN: 00258628     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Di Zerega G. S., Barber D. A., Hogen G. D.: Endometriosis: role of ovarian steroids in initiation, maitenance and suppression. Fertil. Steril. 1980, 33, 649-653.
2. Ferriani R. A., Charnock-Jones D. S., Prentice A., Thomas E. J., Smith S. K.: Immunohistochemical localisation of acids and basic fibroblast growth factors in normal human endometrium and the detection of their mRNA by polymerase chain reaction. Human Reprod. 1993, 8, 11-16.
3. Giudice L. C.: Growth factors and growth modulators in human uterine endometrium: their potential relevance to reproductive medicine. Fertil. Steril. 1994, 61, 1-17.
4. Gleicher N., Pratt D.: Abnormal (auto) immunity and endometriosis. Inst. J. Gynecol. Obstet. Suppl. 1993, 40, 21-27.
5. Hirata J., Kikucki Y., Imaizumi E., Tode T., Nagata I.: Endometric tissue produce immunosupressive factors. Gynecol. Obstet. Invest. 1994, 37, 43-47.
6. Homm R. J., Garza D. E., Mathur S.: Immunological aspects of surgically induced experimental endometriosis: variation in responce to therapy. Fertil. Steril. 1989, 52, 132-139.
7. Hynes R. O.: Integrins: versality, modulation and sygnaling in cell adhesion. Cell 1992, 69, 11-25.
8. Jakowicki J. A. (red.) Endometrioza. Folium, Lublin 1997, 83-97.
9. Kamiński K., Gogacz M., Kotarski J.: Characterization of cellular components in the peritoneal fluid and in endometrial tissue of women with endometriosis. Arch. Immun. Ther. 1995, 43, 247-252.
10. Kiechle F. L., Quottrociocchi-Longe T. M., Briton D.: Carbon anhydrase antibody in sera from patients with endometriosis. Am. J. Clin. Path. 1994, 101, 611-615.
11. Klein N. A., Pergola G. M., Tekmal R. R., Montoya J. A., Dey T. D., Schenken R. S.: Cytokine regulation of cellular proliferation in endometriosis. Ann. N. Y. Acad. Sci. 1994, 734, 322-332.
12. Kobuszewska-Faryna M., Szamborski J.: Histopatologia ginekologiczna. PZWL, Warszawa 1974, 185-190.
13. Laszlo J., Gaal M.: Gynecological pathology. Akad. Kiado, Budapest 1969, 165-170.
14. Madej P., Madej J. A., Kamiński K., Milnerowicz H., Łagan J., Nowak M., Dzimira S.: Immunohistochemiczna lokalizacja metalotioneiny (MT) w endometriozie zewnȩtrznej u kobiet. Gin. Pol. (w druku).
15. Merrill J. A.: Endometrical induction of endometriosis across. Milipore filters. Am. J. Obstet. Gynecol. 1966, 94, 780-789.
16. Olive D. L., Schwartz L. B.: Endometriosis. New. Engl. J. Med. 1993, 328, 1759-1769.
17. Oosterlynck D. J., Lacquet F. A., Waer H., Koninckx P. R.: Lymphokine activated killer activity in women with endometriosis. Gynecol. Obstet. Invest. 1994, 37, 185-190.
18. Oikawa K., Kosugi Y., Ohbayashi T., Kameta A., Isaka K., Takayama M., Koruda M., Mukai K.: Increased expression of IgF dependent histamine releasing factor in endometriotic implants. J. Pathol. 2003, 199, 318-323.
19. Ramey J. W., Archer D. F.: Peritoneal fluid: its relevance to the development of endometriosis. Fertil. Steril. 1993, 60, 1-14.
20. Sainz de la Cuesta R., Eichhorn J. H., Rice L. W., Faller A. F., Nikrio N., Goff B.: Histologic transformation of benign endometriosis to early epithelial ovarian cancer. Gynecol. Oncol. 1996, 60, 2398-244.
21. Schenken R. S., Johnson J. V., Richl R. M.: C myc protooncogen polypeptide expressin in endometriosis. Am. J. Obstet. Gynecol. 1991, 164, 1031-1037.
22. Simms J. S., Chegini N., Willimas R. S., Rossi A. M., Dum W. J.: Identification of epidermal growth factor, transforming growth factor-alfa, and epidermal growth factor receptor in surgical induced endometriosis in the rat. Obstet. Gynecol. 1991, 78, 850-857.
23. Uchiide I., Ihara T., Sugamata M.: Pathological evaluation of the rat endomertiosis model. Fertil. Steril. 2002, 78, 782-786.
24. Yamamoto T., Nogucko T., Tamura T., Kitawaki J., Okada H.: Evidence for estrogen synthesis in adenomyotic tissue. Am. J. Obstet. Gynecol. 1993, 169, 734-738.
25. Vignali M., Infantino M., Matrone R., Chiodo I., Somigliana E., Busacca M., Vigano P.: Endometriosis: novel etiopatogenetic concepts and clinical perspectives. Fertil. Steril. 2002, 78, 665-678.
26. Whitworth Ch. M., Mulholland J., Dunn R. C., Glaser S. R.: Growth factor effects on endometrial epithelial cell differentiation and protein synthesis in vitro. Fertil. Steril. 1994, 61, 91-96.
27. Wild R. A., Medders D., Zhang R.: F (ab) 2 segment in the active component of immunoglobulin G autoantibody generation in patients with endometriosis. Fertil. Steril. 1991, 56, 900-903.
28. Wilson T. J., Hertzog P. J., Arynus D., Munnery L., Wood E. C., Kola J.: Decreased natural killer cell activity in endometriosis patients relationship to disease pathogenesis. Fertil. Steril. 1991, 62, 900-903.
29. Wright S., Valdes S. T., Dunn R. C., Frankin R. R.: Short-term lupron or danazol therapy for pelvic endometriosis. Fertil. Steril. 1995, 63, 504-507.
30. Witz C. A., Montoya J. A., Dey T. D., Schenken R. S.: Characterization of lymphocyte subpopulations and T cell activation in endometriosis. Am. J. Reprod. Immun. 1994, 32, 173-179.